The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks Canada.ca Everything You Need to Know About the FDA Peptide Ban